About Qiagen
Qiagen (FRA:QIA), (NYSE:QGEN) is a multinational entity famed for its provision of sample and assay technologies for molecular diagnostics, applied testing, academic, and pharmaceutical research. The company's offerings include solutions for DNA, RNA, and protein isolation, as well as instrumentation and assays to detect pathogens, genetic disorders, and cancer biomarkers. Qiagen's projects span across developing new testing platforms for infectious diseases, precision medicine, and next-generation sequencing applications, aiming to make improvements in life sciences and health care. Their objective is to streamline the process of extracting, purifying, and analyzing biological materials, making these procedures more efficient and accessible to researchers and healthcare professionals around the globe. Qiagen's commitment to innovation and quality is evident in their continual expansion of their product portfolio, focusing on meeting the rapidly evolving needs of their clients.
Snapshot
Operations
Products and/or services of Qiagen
- Sample and assay technologies for molecular diagnostics used in disease detection, pharmaceutical research, and forensic analysis.
- QuantiFERON-TB Gold Plus test, a modern solution for detecting latent tuberculosis infections.
- QIAcube series for automated sample processing, enhancing laboratory efficiency and consistency in results.
- QIAsymphony, an advanced platform that integrates sample preparation, assay setup, and initial analysis for molecular testing workflows.
- GeneReader NGS System, providing next-generation sequencing solutions for comprehensive genomic profiling in oncology research.
- Digital PCR systems, offering highly sensitive and precise quantitative nucleic acid analysis for research and clinical applications.
Qiagen executive team
- Mr. Thierry BernardCEO, MD & Member of Management Board
- Dr. Roland SackersCFO, MD & Member of Management Board
- Mr. Antonio SantosSenior VP & Head of Global Operations
- Mr. Daniel Wendorff CEFA, CIIAVP & Head of Investor Relations
- Mr. John GilardiVP & Head of Corporate Communications
- Dr. Dominic JohnVice President of Marketing & Product Management
- Ms. Stephany FosterSenior VP & Head of Human Resources
- Dr. Thomas SchweinsSenior Vice President of Life Science Business Area
- Dr. Thomas TheuringerSenior Director & Head of External Communications
- Mr. Jean-Pascal ViolaSenior VP & Head of Corporate Strategy and Business Development